Cargando…

The TNF Paradox in Cancer Progression and Immunotherapy

Detalles Bibliográficos
Autores principales:	Montfort, Anne, Colacios, Céline, Levade, Thierry, Andrieu-Abadie, Nathalie, Meyer, Nicolas, Ségui, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685295/ https://www.ncbi.nlm.nih.gov/pubmed/31417576 http://dx.doi.org/10.3389/fimmu.2019.01818

Ejemplares similares

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019)

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017)

Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
por: Bilal, Fatima, et al.
Publicado: (2019)

New Insights into the Role of Sphingolipid Metabolism in Melanoma
por: Carrié, Lorry, et al.
Publicado: (2020)

The Tricyclodecan-9-yl-xanthogenate D609 Triggers Ceramide Increase and Enhances FasL-Induced Caspase-Dependent and -Independent Cell Death in T Lymphocytes
por: Milhas, Delphine, et al.
Publicado: (2012)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

TNF-R1, an immune checkpoint in melanoma?
por: Bertrand, Florie, et al.
Publicado: (2015)

Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma
por: Mrad, Marguerite, et al.
Publicado: (2016)

Sphingolipids modulate the epithelial–mesenchymal transition in cancer
por: Levade, T, et al.
Publicado: (2015)

Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk
por: Lafont, Elodie, et al.
Publicado: (2010)

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020)

Classical and Paradoxical Effects of TNF-α on Bone Homeostasis
por: Osta, Bilal, et al.
Publicado: (2014)

Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer
por: Dubot, Patricia, et al.
Publicado: (2022)

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
por: Mylonas, Alessio, et al.
Publicado: (2018)

Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy
por: Chen, Chen, et al.
Publicado: (2019)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire
por: Bernard, Isabelle, et al.
Publicado: (2018)

Clinical cancer immunotherapy: Current progress and prospects
por: Liu, Chenglong, et al.
Publicado: (2022)

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
por: Chandra, Janin, et al.
Publicado: (2022)

IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
por: Mas, Emmanuel, et al.
Publicado: (2009)

Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022)

Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis
por: Xie, Wenhui, et al.
Publicado: (2022)

Research Progress in the Application of Exosomes in Immunotherapy
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

The Paradoxical Role of NKG2D in Cancer Immunity
por: Sheppard, Sam, et al.
Publicado: (2018)

A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
por: Shim, Saerok, et al.
Publicado: (2022)

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
por: Butterfield, Lisa H.
Publicado: (2013)

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
por: Romero, Irene, et al.
Publicado: (2018)

Immunodeficiency with Autoimmunity: Beyond the Paradox
por: Bacchetta, R., et al.
Publicado: (2013)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
Publicado: (2021)

Neutrophil extracellular traps in tumor progression and immunotherapy
por: Yan, Meina, et al.
Publicado: (2023)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019)

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
por: Lian, Bi, et al.
Publicado: (2023)

TNF-α Carried by Plasma Extracellular Vesicles Predicts Knee Osteoarthritis Progression
por: Zhang, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpf1natiil8m7nkkl09qoot8n0